Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China flag China · Delayed Price · Currency is CNY
40.89
-0.56 (-1.35%)
May 20, 2026, 11:29 AM CST

SHA:600211 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
2,9892,9782,8003,1282,5452,127
Other Revenue
3.983.986.736.249.6912.06
2,9932,9822,8073,1342,5552,139
Revenue Growth (YoY)
6.34%6.23%-10.45%22.69%19.45%55.75%
Cost of Revenue
185.97171.94162.1158.67204.74225.8
Gross Profit
2,8072,8102,6452,9762,3501,913
Selling, General & Admin
1,7861,7741,6851,8811,5411,254
Research & Development
95.2874.0828.9417.3588.1360.86
Other Operating Expenses
-48.1637.7237.138.1732.5426.2
Operating Expenses
1,8331,8851,7511,9371,6621,340
Operating Income
974.36924.66893.441,039688.27572.75
Interest Expense
-24.6-12.59-9.48-11.59-14.36-4.33
Interest & Investment Income
65.958874.3886.2221.352.67
Currency Exchange Gain (Loss)
1.311.31-2.47-0.11-3.83-4.78
Other Non Operating Income (Expenses)
-0.05-0.12-0.17-0.47-0.39-0.35
EBT Excluding Unusual Items
1,0171,001955.691,113691.03565.96
Gain (Loss) on Sale of Investments
-4.44-3.72-18.99-210.53-14.17146.47
Gain (Loss) on Sale of Assets
0.080.081.90.34-0.23-0.17
Asset Writedown
----190.38-218.62-458.06
Other Unusual Items
4343213.48186.035.360.64
Pretax Income
1,0561,0411,152898.19463.39254.85
Income Tax Expense
126.04123.6495.0187.9588.0841.82
Earnings From Continuing Operations
929.57916.981,057810.24375.31213.03
Minority Interest in Earnings
37.7920.95-5.79-9.33-5.47-4.09
Net Income
967.36937.931,051800.91369.84208.94
Net Income to Common
967.36937.931,051800.91369.84208.94
Net Income Growth
-4.00%-10.78%31.26%116.56%77.01%-50.03%
Shares Outstanding (Basic)
322322322323323323
Shares Outstanding (Diluted)
322322322323323323
Shares Change (YoY)
0.15%-0.05%-0.14%0.09%-0.21%0.53%
EPS (Basic)
3.002.913.262.481.150.65
EPS (Diluted)
3.002.913.262.481.150.65
EPS Growth
-4.15%-10.74%31.45%116.37%77.38%-50.29%
Free Cash Flow
1,064988.79957.191,042735.41-59.05
Free Cash Flow Per Share
3.303.072.973.232.28-0.18
Dividend Per Share
1.7571.7571.9571.4920.5740.260
Dividend Growth
-10.22%-10.22%31.21%159.93%120.69%-33.72%
Gross Margin
93.79%94.23%94.23%94.94%91.98%89.44%
Operating Margin
32.55%31.01%31.83%33.14%26.94%26.78%
Profit Margin
32.32%31.46%37.46%25.55%14.48%9.77%
Free Cash Flow Margin
35.55%33.16%34.10%33.24%28.79%-2.76%
EBITDA
1,0521,002968.641,107757.52654.2
EBITDA Margin
35.16%33.61%34.51%35.31%29.65%30.59%
D&A For EBITDA
78.0377.4775.268.0569.2481.45
EBIT
974.36924.66893.441,039688.27572.75
EBIT Margin
32.55%31.01%31.83%33.14%26.94%26.78%
Effective Tax Rate
11.94%11.88%8.25%9.79%19.01%16.41%
Revenue as Reported
2,9932,9822,807-2,5552,139
Advertising Expenses
-10.18.723.50.050.24
Source: S&P Global Market Intelligence. Standard template. Financial Sources.